BCL2L2靶向药基因

基因名称:BCL2L2  (BCL2 like 2)

别名: BCLW,BCL-W,PPP1R51,BCL2-L-2
基因ID:599
Chromosome(GRCh37) :14 Start: 23775971 End: 23790241 Strand:
信号通路: 凋亡抑制
靶向药:
化疗药:

简介:这个基因编码bcl-2蛋白家族的一个成员。这个家族的蛋白质形成异二聚体或同二聚体,并作为抗和促凋亡的调节因子。在细胞毒性条件下,该基因在细胞中的表达有助于减少细胞凋亡。对小鼠相关基因的研究表明,ngf和bdnf依赖神经元的存活与此有关。小鼠基因的突变和敲除研究表明在成年精子发生中起着重要作用。选择性剪接导致多个转录变体。该基因与邻近的下游pabpn1(poly(a)结合蛋白,nuclear 1)基因之间也存在读写转录。[由RefSeq提供,2010年12月]This gene encodes a member of the BCL-2 protein family. The proteins of this family form hetero- or homodimers and act as anti- and pro-apoptotic regulators. Expression of this gene in cells has been shown to contribute to reduced cell apoptosis under cytotoxic conditions. Studies of the related gene in mice indicated a role in the survival of NGF- and BDNF-dependent neurons. Mutation and knockout studies of the mouse gene demonstrated an essential role in adult spermatogenesis. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the neighboring downstream PABPN1 (poly(A) binding protein, nuclear 1) gene. [provided by RefSeq, Dec 2010]
BCL2L2突变与药物:

常见问题
  • 如何在体龙基因完成所需的检测项目 流程简述 :在线咨询 - 采样送检 - 付款检测 - 检测分析 - 报告结果
查看详情

相关内容

官方客服团队

为您解决烦忧 - 24小时在线 专业服务